Results 181 to 190 of about 756,003 (352)
A NOVEL AND SIMPLE RULE OF THUMB FOR MULTIPLICITY CONTROL IN EQUIVALENCE TESTING USING TWO ONE-SIDED TESTS [PDF]
Equivalence testing is growing in use in scientific research outside of its traditional role in the drug approval process. Largely due to its ease of use and recommendation from the United States Food and Drug Administration guidance, the most common ...
Caffo, Brian S., Lauzon, Carolyn
core +1 more source
Drug-induced torsades de pointes: Disproportionality analysis of the United States Food and Drug Administration adverse event reporting system. [PDF]
Wu Z, Zhou P, He N, Zhai S.
europepmc +1 more source
Bio‐based and (semi‐)synthetic zwitterion‐modified novel materials and fully synthetic next‐generation alternatives show the importance of material design for different biomedical applications. The zwitterionic character affects the physiochemical behavior of the material and deepens the understanding of chemical interaction mechanisms within the ...
Theresa M. Lutz +3 more
wiley +1 more source
Is Tobacco a Drug? Administrative Agencies as Common Law Courts [PDF]
Professor Cass Sunstein argues that the FDA has the authority to regulate tobacco products. He considers the text of the Federal Food, Drug, and Cosmetic Act, which supports the FDA assertion, and the context of its enactment, which argues against the ...
Sunstein, Cass Robert
core
Topic modeling is a crucial technique in natural language processing (NLP), enabling the extraction of latent themes from large text corpora. Traditional topic modeling, such as Latent Dirichlet Allocation (LDA), faces limitations in capturing the ...
Li Ma +9 more
doaj +1 more source
Doxycycline use and adverse pregnancy or neonatal outcomes: A descriptive study using the United States Food and Drug Administration Adverse Event Reporting System database. [PDF]
Kaundinnyayana S, Kamath A.
europepmc +1 more source
PCN112 Cyclin Dependent Kinase (CDK) 4/6 Inhibitors and LUNG Inflammation: An Analysis of the United States FOOD and Drug Administrations' Adverse Event Reporting System [PDF]
Eric P. Borrelli, Conor G. McGladrigan
openalex +1 more source

